A recent study by Careccia et al. was paramount in implicating HMGB1 in DMD-related inflammation characterizing HMGB1 as a therapeutic target with its oxidative state influencing its role in inflammation and skeletal muscle regeneration (Careccia et al., 2021). This evidence concerns the gene HMGB1 and Duchenne muscular dystrophy.